Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,609 | -2,771 | -4,167 | -4,114 | -4,053 |
| Depreciation Amortization | 179 | 157 | 160 | 173 | 29 |
| Accounts payable and accrued liabilities | -5 | 130 | 36 | -145 | 156 |
| Other Working Capital | 136 | 287 | -140 | -44 | 550 |
| Other Operating Activity | 40 | 44 | 17 | 179 | -49 |
| Operating Cash Flow | $-1,259 | $-2,153 | $-4,094 | $-3,951 | $-3,367 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 4 | 172 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -378 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -378 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $4 | $-206 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,000 | N/A | N/A | N/A |
| Other Financing Activity | 946 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $946 | $1,000 | $0 | $N/A | $0 |
| Beginning Cash Position | 1,011 | 2,164 | 6,258 | 10,205 | 13,778 |
| End Cash Position | 698 | 1,011 | 2,164 | 6,258 | 10,205 |
| Net Cash Flow | $-313 | $-1,153 | $-4,094 | $-3,947 | $-3,573 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,259 | -2,153 | -4,094 | -3,951 | -3,367 |
| Free Cash Flow | -1,259 | -2,153 | -4,094 | -3,951 | -3,367 |